🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Driving with Neuropathy

RecruitingNAAges 25 Years - 69 YearsAllManchester Metropolitan University
NCT06739135 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a proof-of-concept randomised controlled trial (RCT). The goal of the study is to investigate the effectiveness of a feedback intervention to improve use of the accelerator pedal in patients driving with diabetes and peripheral neuropathy (DPN). The main (primary) question it aims to answer is: What is the effect of a visual feedback intervention (over 6 sessions a month apart), compared to no feedback, on accelerator pedal use by drivers with diabetic peripheral neuropathy? Our working hypothesis is that the visual feedback intervention will reduce the % of drive time with the accelerator pedal pushed down further than 9 degrees (about halfway down), the point at which the visual feedback (a warning signal) is triggered. Secondary research questions are: 1. What is the effect of the feedback intervention on drivers with diabetic peripheral neuropathy at the first visi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Able to understand English and all of the study requirements, including ability to provide informed consent * Current full UK driving licence held, and for a minimum of 5 years (experienced drivers) * Drives a car at least once per week on average (current drivers) * Diagnosed with type 2 diabetes and diabetic peripheral neuropathy * Diagnosed with type 2 diabetes only (no diagnosed diabetic peripheral neuropathy) Exclusion Criteria: * Active foot ulcer on either foot * Lower limb amputation involving more than two toes on the right foot * Dementia * Current participation in another research study that would compromise safety, or scientific integrity of either study (for example, a pharmaceutical trial that may affect ability to drive safely).
💊

What it tests

  • Visual feedback training
📍

Where

1 site
Manchester Metropolitan University
Manchester, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy